Literature DB >> 6407695

Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer.

B Petersson, E Trell.   

Abstract

Low serum cholesterol concentrations are associated with deaths from cancer. This association was found in a prospective study of middle aged men in Malmö and consideration of possible explanations for the lowering of serum cholesterol prompted an analysis of serum urate in relation to deaths from cancer. A total of 127 of the 7725 participants in the Malmö study had died since screening. A weakly positive but significant correlation between raised serum urate concentration and total mortality was found. This correlation was wholly explained by neoplastic deaths (p less than 0.01), while there were no associations with alcohol related deaths or with deaths from coronary heart disease. When the deaths from cancer were classified as "early" or "late"--that is, occurring less than or more than 2.5 years after the screening--the correlation between raised urate concentrations and cancer mortality was confined to the "early" deaths (p less than 0.001). Further studies are needed to substantiate the relation between raised serum urate concentrations and fatal neoplasia. Nevertheless, these findings weigh against recent suggestions that uric acid has an antioxidant protective effect against cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407695      PMCID: PMC1548148          DOI: 10.1136/bmj.287.6384.7

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Population serum urate levels and their correlates. The Sherbrooke regional study.

Authors:  L Munan; A Kelly; C Petitclerc
Journal:  Am J Epidemiol       Date:  1976-04       Impact factor: 4.897

2.  Serum uric acid levels in women. An epidemiological survey with special reference to women with high serum uric acid values.

Authors:  C Bengtsson; E Tibblin
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

3.  Correlates and consequences of asymptomatic hyperuricemia.

Authors:  W J Fessel; A B Siegelaub; E S Johnson
Journal:  Arch Intern Med       Date:  1973-07

4.  Uric acid in alcoholics.

Authors:  J S Olin; P Devenyi; K L Weldon
Journal:  Q J Stud Alcohol       Date:  1973-12

5.  The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia.

Authors:  J D Kark; A H Smith; C G Hames
Journal:  J Chronic Dis       Date:  1980

6.  Uric acid: a risk factor for coronary heart disease?

Authors:  V W Persky; A R Dyer; E Idris-Soven; J Stamler; R B Shekelle; J A Schoenberger; D M Berkson; H A Lindberg
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  Elevation of serum uric acid as a clue to alcohol abuse.

Authors:  D E Drum; P A Goldman; C B Jankowski
Journal:  Arch Intern Med       Date:  1981-03

8.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Plasma lipids and mortality: a source of error.

Authors:  G Rose; M J Shipley
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

10.  Low cholesterol level as risk factor for noncoronary death in middle-aged men.

Authors:  B Peterson; E Trell; N H Sternby
Journal:  JAMA       Date:  1981 May 22-29       Impact factor: 56.272

View more
  13 in total

1.  "Healthometer"--an instrument for self-distributed health screening and prevention in the population.

Authors:  L Spång; E Trell; M Fioretos; V Kielstein; M Nasr
Journal:  J Med Syst       Date:  1998-10       Impact factor: 4.460

Review 2.  Insight into rheumatological cause and effect through the use of Mendelian randomization.

Authors:  Philip C Robinson; Hyon K Choi; Ron Do; Tony R Merriman
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

3.  Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?

Authors:  M Grootveld; B Halliwell
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 4.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

5.  Premature mortality in middle-aged men: serum cholesterol as risk factor.

Authors:  B Peterson; E Trell
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.

Authors:  Ozgur Tanriverdi; Suna Cokmert; Esin Oktay; Kezban Nur Pilanci; Serkan Menekse; Muharrem Kocar; Cenk Ahmet Sen; Nilufer Avci; Tulay Akman; Cetin Ordu; Gamze Goksel; Nezih Meydan
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

7.  Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.

Authors:  Stephen P Juraschek; Hugh Tunstall-Pedoe; Mark Woodward
Journal:  Atherosclerosis       Date:  2014-01-30       Impact factor: 5.162

8.  Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.

Authors:  Jeremy G Wheeler; Kelsey D M Juzwishin; Gudny Eiriksdottir; Vilmundur Gudnason; John Danesh
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

9.  Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study.

Authors:  N Taghizadeh; J M Vonk; H M Boezen
Journal:  Cancer Causes Control       Date:  2014-06-07       Impact factor: 2.506

10.  Contribution of uric acid to cancer risk, recurrence, and mortality.

Authors:  Mehdi A Fini; Anthony Elias; Richard J Johnson; Richard M Wright
Journal:  Clin Transl Med       Date:  2012-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.